Intermittent vs. Continuous Dorsal Root Ganglion Stimulation
Active, not recruitingNot applicableNCT04727216
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain
Study details
- Official title
- Intermittent Dorsal Root Ganglion Stimulation Dosing Comparison to Standard Continuous Dosing in Treating Chronic Pain
- Conditions
- Interventions
- Device: Dorsal Root Ganglion Stimulation (DRG-S)
- Sponsor
- Spine and Pain Institute of New York
- Start date
- 2021-03-23
- Primary completion
- 2021-08-01
- Sex
- All
- Age range
- from 21 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject is able to provide informed consent to participate in the study; * Subject is 21 years of age or older; * Subject has been treated with DRG-S permanent implant device (Abbott, Plano, TX, USA) for a minimum of 3 months with sustained pain relief \>50% for chronic intractable pain; * Subject's DRG-S parameters have remained unchanged for at least 30 days prior to the beginning of the study Exclusion Criteria: * Subject had a recent change in pain medication regimen resulting in increase in Morphine Milligram Equivalent dosing within 60 days prior to the beginning of the study * Subject received an additional pain interventional procedure within 60 days prior to the beginning of the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04727216